<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Nature Precedings - Aaron Filler</title>
    <link>http://precedings.nature.com/users/b70abde0ac72aa7b10a33f41ee03579f/</link>
    <description>Documents posted by Aaron Filler</description>
    <dc:publisher>Nature Publishing Group</dc:publisher>
    <dc:language>en</dc:language>
    <prism:publicationName>Nature Precedings</prism:publicationName>
    <image>
      <title>Nature Precedings</title>
      <url>http://precedings.nature.com/images/header_logo.gif</url>
      <link>http://precedings.nature.com</link>
    </image>
    <atom:link type="application/rss+xml" rel="self" href="http://precedings.nature.com/users/b70abde0ac72aa7b10a33f41ee03579f/feed"/>
    <item>
      <title>The History, Development and Impact of Computed Imaging in Neurological Diagnosis and Neurosurgery: CT, MRI, and DTI</title>
      <link>http://dx.doi.org/10.1038/npre.2009.3267.5</link>
      <description>A steady series of advances in physics, mathematics, computers and clinical imaging science have progressively transformed diagnosis and treatment of neurological and neurosurgical disorders in the 115 years between the discovery of the X-ray and the advent of high resolution diffusion based functional MRI. The story of the progress in human terms, with its battles for priorities, forgotten advances, competing claims, public battles for Nobel Prizes, and patent priority litigations bring alive the human drama of this remarkable collective achievement in computed medical imaging.</description>
      <guid>http://dx.doi.org/10.1038/npre.2009.3267.5</guid>
      <pubDate>Mon, 13 Jul 2009 09:15:30 UTC</pubDate>
      <dc:title>The History, Development and Impact of Computed Imaging in Neurological Diagnosis and Neurosurgery: CT, MRI, and DTI</dc:title>
      <dc:identifier>doi:10.1038/npre.2009.3267.5</dc:identifier>
      <dc:date>2009-07-13</dc:date>
      <dc:creator>Aaron G. Filler</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2009-07-13T09:15:30Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Biotechnology</prism:section>
      <prism:section>Cancer</prism:section>
      <prism:section>Neuroscience</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/3267/version/5/files/npre20093267-5.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/3.0/</creativeCommons:license>
    </item>
    <item>
      <title>MR Neurography and Diffusion Tensor Imaging:  Origins, History &amp;#38; Clinical Impact </title>
      <link>http://dx.doi.org/10.1038/npre.2009.2877.2</link>
      <description>Objective &#8211; Methods were invented that made it possible to image peripheral nerves in the body and to image neural tracts in the brain. Over a 15 year period, these techniques &#8211; MR Neurography and Diffusion Tensor Imaging &#8211; were then deployed in the clinical and research community and applied to about 50,000 patients. Within this group, about 5,000 patients having MR Neurography were carefully tracked on a prospective basis.Method &#8211; In the study group a uniform imaging methodology was applied and all images were reviewed and registered by referral source, clinical indication, efficacy of imaging and quality. Various classes of image findings were identified and subjected to a variety of small targeted prospective outcome studies. Those findings demonstrated to be clinically significant were then tracked in the larger clinical volume data set.Results &#8211; MR Neurography demonstrates mechanical distortion of nerves, hyperintensity consistent with nerve irritation, nerve swelling, discontinuity, relations of nerves to masses, and image features revealing distortion of nerve at entrapment points. These findings are often clinically relevant and warrant full consideration in the diagnostic process. They result in specific pathologic diagnoses that are comparable to electrodiagnostic testing in clinical efficacy.Conclusions &#8211; MR Neurography and DTI neural tract imaging have been validated as indispensable clinical diagnostic methods that provide reliable anatomical pathological information. There is no alternative diagnostic method in many situations. With the elapse of 15 years, tens of thousands of imaging studies, and hundreds of  publications, these methods should no longer be considered experimental.</description>
      <guid>http://dx.doi.org/10.1038/npre.2009.2877.2</guid>
      <pubDate>Tue, 07 Apr 2009 13:23:59 UTC</pubDate>
      <dc:title>MR Neurography and Diffusion Tensor Imaging:  Origins, History &amp;#38; Clinical Impact </dc:title>
      <dc:identifier>doi:10.1038/npre.2009.2877.2</dc:identifier>
      <dc:date>2009-04-07</dc:date>
      <dc:creator>Aaron G. Filler</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2009-04-07T13:23:59Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Neuroscience</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/2877/version/2/files/npre20092877-2.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/3.0/</creativeCommons:license>
    </item>
    <item>
      <title>MR Neurography and Diffusion Tensor Imaging: Origin, History and Impact</title>
      <link>http://precedings.nature.com/documents/1932/version/2</link>
      <description>Objective: Methods were invented that made it possible to image peripheral nerves in the body and to image neural tracts in the brain. Over a 15 year period, these techniques &#8211; MR Neurography and Diffusion Tensor Imaging &#8211; were then deployed in the clinical and research community and applied to about 50,000 patients. Within this group, about 5,000 patients having MR Neurography were carefully tracked on a prospective basis.Method: In the study group a uniform imaging methodology was applied and all images were reviewed and registered by referral source, clinical indication, efficacy of imaging and quality. Various classes of image findings were identified and subjected to a variety of small targeted prospective outcome studies. Those findings demonstrated to be clinically significant were then tracked in the larger clinical volume data set.Results: MR Neurography demonstrates mechanical distortion of nerves, hyperintensity consistent with nerve irritation, nerve swelling, discontinuity, relations of nerves to masses, and image features revealing distortion of nerve at entrapment points. These findings are often clinically relevant and warrant full consideration in the diagnostic process. They result in specific pathologic diagnoses that are comparable to electrodiagnostic testing in clinical efficacy.Conclusions: MR Neurography and DTI neural tract imaging have been validated as indispensable clinical diagnostic methods that provide reliable anatomical pathological information. There is no alternative diagnostic method in many situations. With the elapse of 15 years, tens of thousands of imaging studies, and hundreds of publications, these methods should no longer be considered experimental.</description>
      <guid>http://precedings.nature.com/documents/1932/version/2</guid>
      <pubDate>Thu, 13 Nov 2008 16:57:13 UTC</pubDate>
      <dc:title>MR Neurography and Diffusion Tensor Imaging: Origin, History and Impact</dc:title>
      <dc:identifier>hdl:10101/npre.2008.1932.2</dc:identifier>
      <dc:date>2008-11-13</dc:date>
      <dc:creator>Aaron G. Filler</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2008-11-13T16:57:13Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Neuroscience</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/1932/version/2/files/npre20081932-2.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/3.0/</creativeCommons:license>
    </item>
    <item>
      <title>Successful use of axonal transport for drug delivery by synthetic molecular vehicles</title>
      <link>http://precedings.nature.com/documents/2164/version/1</link>
      <description>We report the use of axonal transport to achieve intraneural drug delivery. We constructed a novel tripartite complex of an axonal transport facilitator conjugated to a linker molecule bearing up to a hundred reversibly attached drug molecules. The complex efficiently enters nerve terminals after intramuscular or intradermal administration and travels within axonal processes to neuron cell bodies. The tripartite agent provided 100-fold amplification of saturable neural uptake events, delivering multiple drug molecules per complex. In vivo, analgesic drug delivery to systemic and to non-targeted neural tissues was greatly reduced compared to existing routes of administration, thus exemplifying the possibility of specific nerve root targeting and effectively increasing the potency of the candidate drug gabapentin 300-fold relative to oral administration.</description>
      <guid>http://precedings.nature.com/documents/2164/version/1</guid>
      <pubDate>Thu, 07 Aug 2008 12:00:47 UTC</pubDate>
      <dc:title>Successful use of axonal transport for drug delivery by synthetic molecular vehicles</dc:title>
      <dc:identifier>hdl:10101/npre.2008.2164.1</dc:identifier>
      <dc:date>2008-08-07</dc:date>
      <dc:creator>Aaron G. Filler</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2008-08-07T12:00:47Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Biotechnology</prism:section>
      <prism:section>Chemistry</prism:section>
      <prism:section>Molecular Cell Biology</prism:section>
      <prism:section>Neuroscience</prism:section>
      <prism:section>Pharmacology</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/2164/version/1/files/npre20082164-1.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/3.0/</creativeCommons:license>
    </item>
  </channel>
</rss>
